1 minute read
The Food and Drug Administration (FDA) has authorized a second COVID-19 booster dose for people aged 50 and older and individuals who are immunocompromised. The new booster can be administered four months after the first booster dose.
In April, the FDA’s vaccine advisory committee will discuss the possibility of booster shots in other age groups as new coronavirus variants circulate.
Individuals should continue to monitor the FDA’s guidance for updates. Contact your health care provider to learn more about COVID-19 booster eligibility and vaccines in general.
Download the bulletin for more details.
This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.
National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.
